MGI
NVO

Miller Global Investments’s Novo Nordisk NVO Stock Holding History

Miller Global Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Hold
2,831
– – 0.11% 158
2026
Q1 		$104K Sell
2,831
-13
-0.5% -$616 0.1% 156
2025
Q4 		$145K Buy
+2,844
New +$145K 0.13% 142

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Miller Global Investments's NVO Position: Q2 2026 in Review

Miller Global Investments held its Novo Nordisk (NVO) position steady in Q2 2026 at 2,831 shares worth $136K. The position accounts for 0.11% of the portfolio, ranked #158.

Miller Global Investments first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $145K in Q4 2025. 712 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Miller Global Investments held 2,831 shares of Novo Nordisk worth $136K as of Q2 2026.
  • Miller Global Investments left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.11% of Miller Global Investments's portfolio in Q2 2026, its #158 holding.
  • Miller Global Investments first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Novo Nordisk position peaked at $145K in Q4 2025.
  • 712 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.